Tokyo Tape
Sign in
← Leoclan

Annual report

7681.TEDINET S100PU2R
Period2021-10-01 → 2022-09-30
Filed2022-12-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 154
MetricValuePeriodScopeSource row
Revenue¥29.8bn2021-10-01 → 2022-09-30Cons.Net sales
Revenue¥26.3bn2020-10-01 → 2021-09-30Cons.Net sales
Revenue¥22.0bn2019-10-01 → 2020-09-30dCons.Net sales (5-year summary)
Revenue¥36.1bn2018-10-01 → 2019-09-30dCons.Net sales (5-year summary)
Revenue¥25.7bn2017-10-01 → 2018-09-30dCons.Net sales (5-year summary)
Operating income¥651m2021-10-01 → 2022-09-30Cons.Operating income
Operating income¥576m2020-10-01 → 2021-09-30Cons.Operating income
Ordinary income¥710m2021-10-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥596m2020-10-01 → 2021-09-30Cons.Ordinary income
Ordinary income¥207m2019-10-01 → 2020-09-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥1.2bn2018-10-01 → 2019-09-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥652m2017-10-01 → 2018-09-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥690m2021-10-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥595m2020-10-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥437m2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥391m2020-10-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥121m2019-10-01 → 2020-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥733m2018-10-01 → 2019-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥358m2017-10-01 → 2018-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥471m2021-10-01 → 2022-09-30Cons.Profit loss
Net income¥410m2020-10-01 → 2021-09-30Cons.Profit loss
Total assets¥13.5bnat 2022-09-30Cons.Assets
Total assets¥13.0bnat 2021-09-30Cons.Assets
Total assets¥13.4bnat 2020-09-30dCons.Total assets (5-year summary)
Total assets¥12.8bnat 2019-09-30dCons.Total assets (5-year summary)
Total assets¥12.9bnat 2018-09-30dCons.Total assets (5-year summary)
Total liabilities¥7.9bnat 2022-09-30Cons.Liabilities
Total liabilities¥7.8bnat 2021-09-30Cons.Liabilities
Net assets / equity¥5.5bnat 2022-09-30Cons.Net assets
Net assets / equity¥5.2bnat 2021-09-30Cons.Net assets
Net assets / equity¥4.8bnat 2020-09-30dCons.Net assets
Net assets / equity¥4.3bnat 2019-09-30dCons.Net assets (5-year summary)
Net assets / equity¥3.7bnat 2018-09-30dCons.Net assets (5-year summary)
Cash and deposits¥5.5bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥5.4bnat 2021-09-30Cons.Cash and deposits
Cash & equivalents¥5.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.4bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥4.4bnat 2020-09-30dCons.Cash and cash equivalents
Cash & equivalents¥6.2bnat 2019-09-30dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥3.7bnat 2018-09-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥242m2021-10-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.3bn2020-10-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥1.9bn2019-10-01 → 2020-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.8bn2018-10-01 → 2019-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥963m2017-10-01 → 2018-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥50m2021-10-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥42m2020-10-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥64m2019-10-01 → 2020-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥92m2018-10-01 → 2019-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥53m2017-10-01 → 2018-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥121m2021-10-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥298m2020-10-01 → 2021-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥238m2019-10-01 → 2020-09-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥213m2018-10-01 → 2019-09-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥203m2017-10-01 → 2018-09-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥222.92021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥199.922020-10-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥62.512019-10-01 → 2020-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥411.312018-10-01 → 2019-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥323.642017-10-01 → 2018-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥221.522021-10-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥198.332020-10-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥61.852019-10-01 → 2020-09-30dCons.Diluted earnings per share (5-year summary)
Net assets per share¥2,746.25at 2022-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥2,567.33at 2021-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥2,408.78at 2020-09-30dCons.Net assets per share (5-year summary)
Net assets per share¥2,376.58at 2019-09-30dCons.Net assets per share (5-year summary)
Net assets per share¥2,016.04at 2018-09-30dCons.Net assets per share (5-year summary)
Equity ratio40.0%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio38.8%at 2021-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio35.1%at 2020-09-30dCons.Equity to asset ratio (5-year summary)
Equity ratio33.0%at 2019-09-30dCons.Equity to asset ratio (5-year summary)
Equity ratio27.9%at 2018-09-30dCons.Equity to asset ratio (5-year summary)
ROE8.4%2021-10-01 → 2022-09-30Cons.Rate of return on equity (5-year summary)
ROE8.0%2020-10-01 → 2021-09-30Cons.Rate of return on equity (5-year summary)
ROE2.7%2019-10-01 → 2020-09-30dCons.Rate of return on equity (5-year summary)
ROE18.7%2018-10-01 → 2019-09-30dCons.Rate of return on equity (5-year summary)
ROE11.2%2017-10-01 → 2018-09-30dCons.Rate of return on equity (5-year summary)
Employees175at 2022-09-30Cons.Number of employees
Employees162at 2021-09-30Cons.Number of employees
Employees157at 2020-09-30dCons.Number of employees
Employees155at 2019-09-30dCons.Number of employees
Employees153at 2018-09-30dCons.Number of employees
Revenue¥27.3bn2021-10-01 → 2022-09-30StandaloneNet sales
Revenue¥23.4bn2020-10-01 → 2021-09-30StandaloneNet sales
Revenue¥19.7bn2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Revenue¥32.8bn2018-10-01 → 2019-09-30dStandaloneNet sales (5-year summary)
Revenue¥23.4bn2017-10-01 → 2018-09-30dStandaloneNet sales (5-year summary)
Operating income¥420m2021-10-01 → 2022-09-30StandaloneOperating income
Operating income¥398m2020-10-01 → 2021-09-30StandaloneOperating income
Ordinary income¥448m2021-10-01 → 2022-09-30StandaloneOrdinary income
Ordinary income¥435m2020-10-01 → 2021-09-30StandaloneOrdinary income
Ordinary income¥234m2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.1bn2018-10-01 → 2019-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥707m2017-10-01 → 2018-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥428m2021-10-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax¥435m2020-10-01 → 2021-09-30StandaloneIncome before income taxes
Net income¥294m2021-10-01 → 2022-09-30StandaloneProfit loss
Net income¥297m2020-10-01 → 2021-09-30StandaloneProfit loss
Net income¥194m2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Net income¥704m2018-10-01 → 2019-09-30dStandaloneNet income loss (5-year summary)
Net income¥476m2017-10-01 → 2018-09-30dStandaloneNet income loss (5-year summary)
Total assets¥12.3bnat 2022-09-30StandaloneAssets
Total assets¥11.8bnat 2021-09-30StandaloneAssets
Total assets¥12.7bnat 2020-09-30dStandaloneTotal assets (5-year summary)
Total assets¥11.8bnat 2019-09-30dStandaloneTotal assets (5-year summary)
Total assets¥12.0bnat 2018-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥7.2bnat 2022-09-30StandaloneLiabilities
Total liabilities¥7.0bnat 2021-09-30StandaloneLiabilities
Net assets / equity¥5.0bnat 2022-09-30StandaloneNet assets
Net assets / equity¥4.8bnat 2021-09-30StandaloneNet assets
Net assets / equity¥4.6bnat 2020-09-30dStandaloneNet assets
Net assets / equity¥4.0bnat 2019-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥3.4bnat 2018-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥4.5bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥4.6bnat 2021-09-30StandaloneCash and deposits
EPS (basic)¥149.722021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥151.612020-10-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥100.582019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥394.832018-10-01 → 2019-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥430.722017-10-01 → 2018-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥148.792021-10-01 → 2022-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥150.412020-10-01 → 2021-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥99.532019-10-01 → 2020-09-30dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥502021-10-01 → 2022-09-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥402020-10-01 → 2021-09-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥452019-10-01 → 2020-09-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥402018-10-01 → 2019-09-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥402017-10-01 → 2018-09-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,560.72at 2022-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥2,454.98at 2021-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥2,344.4at 2020-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,264.68at 2019-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,920.63at 2018-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio40.9%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio40.9%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio36.2%at 2020-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio34.2%at 2019-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio28.4%at 2018-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE6.0%2021-10-01 → 2022-09-30StandaloneRate of return on equity (5-year summary)
ROE6.3%2020-10-01 → 2021-09-30StandaloneRate of return on equity (5-year summary)
ROE4.5%2019-10-01 → 2020-09-30dStandaloneRate of return on equity (5-year summary)
ROE18.9%2018-10-01 → 2019-09-30dStandaloneRate of return on equity (5-year summary)
ROE16.0%2017-10-01 → 2018-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued1,960,800at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued1,960,800at 2021-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued1,954,400at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,784,000at 2019-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,784,000at 2018-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees134at 2022-09-30StandaloneNumber of employees
Employees118at 2021-09-30StandaloneNumber of employees
Employees114at 2020-09-30dStandaloneNumber of employees
Employees107at 2019-09-30dStandaloneNumber of employees
Employees105at 2018-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Reconciling Itemsreconcilingdepreciation2021-10-01 → 2022-09-30−¥26,000
Reconciling Itemsreconcilingsegment assetsat 2022-09-30−¥146m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-09-30¥3m
Food Servicereportable segmentcapex2021-10-01 → 2022-09-30¥10m
Food Servicereportable segmentdepreciation2021-10-01 → 2022-09-30¥7m
Food Servicereportable segmentemployeesat 2022-09-3016 pure
Food Servicereportable segmentrevenue2021-10-01 → 2022-09-30¥403m
Food Servicereportable segmentrevenue external2021-10-01 → 2022-09-30¥403m
Food Servicereportable segmentsegment assetsat 2022-09-30¥180m
Food Servicereportable segmentsegment profit2021-10-01 → 2022-09-30¥7m
Remote Image Diagnosis Service Businessreportable segmentcapex2021-10-01 → 2022-09-30¥4m
Remote Image Diagnosis Service Businessreportable segmentdepreciation2021-10-01 → 2022-09-30¥10m
Remote Image Diagnosis Service Businessreportable segmentemployeesat 2022-09-3014 pure
Remote Image Diagnosis Service Businessreportable segmentrevenue2021-10-01 → 2022-09-30¥676m
Remote Image Diagnosis Service Businessreportable segmentrevenue external2021-10-01 → 2022-09-30¥676m
Remote Image Diagnosis Service Businessreportable segmentsegment assetsat 2022-09-30¥559m
Remote Image Diagnosis Service Businessreportable segmentsegment profit2021-10-01 → 2022-09-30¥67m
Total Medical Solution Businessreportable segmentcapex2021-10-01 → 2022-09-30¥43m
Total Medical Solution Businessreportable segmentdepreciation2021-10-01 → 2022-09-30¥79m
Total Medical Solution Businessreportable segmentemployeesat 2022-09-30145 pure
Total Medical Solution Businessreportable segmentrevenue2021-10-01 → 2022-09-30¥28.7bn
Total Medical Solution Businessreportable segmentrevenue external2021-10-01 → 2022-09-30¥28.7bn
Total Medical Solution Businessreportable segmentsegment assetsat 2022-09-30¥12.9bn
Total Medical Solution Businessreportable segmentsegment profit2021-10-01 → 2022-09-30¥574m
Total Of Reportable Segments And Otherssegment totalcapex2021-10-01 → 2022-09-30¥57m
Total Of Reportable Segments And Otherssegment totaldepreciation2021-10-01 → 2022-09-30¥96m
Total Of Reportable Segments And Otherssegment totalrevenue2021-10-01 → 2022-09-30¥29.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-10-01 → 2022-09-30¥29.8bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-09-30¥13.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-10-01 → 2022-09-30¥648m
Reconciling Itemsreconcilingdepreciation2020-10-01 → 2021-09-30−¥147,000
Reconciling Itemsreconcilingrevenue2020-10-01 → 2021-09-30−¥128,000
Reconciling Itemsreconcilingrevenue intersegment2020-10-01 → 2021-09-30−¥128,000
Reconciling Itemsreconcilingsegment assetsat 2021-09-30−¥146m
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-09-30¥3m
Food Servicereportable segmentcapex2020-10-01 → 2021-09-30¥10m
Food Servicereportable segmentdepreciation2020-10-01 → 2021-09-30¥6m
Food Servicereportable segmentrevenue2020-10-01 → 2021-09-30¥464m
Food Servicereportable segmentrevenue external2020-10-01 → 2021-09-30¥464m
Food Servicereportable segmentsegment assetsat 2021-09-30¥184m
Food Servicereportable segmentsegment profit2020-10-01 → 2021-09-30¥37m
Remote Image Diagnosis Service Businessreportable segmentcapex2020-10-01 → 2021-09-30¥10m
Remote Image Diagnosis Service Businessreportable segmentdepreciation2020-10-01 → 2021-09-30¥14m
Remote Image Diagnosis Service Businessreportable segmentrevenue2020-10-01 → 2021-09-30¥647m
Remote Image Diagnosis Service Businessreportable segmentrevenue external2020-10-01 → 2021-09-30¥647m
Remote Image Diagnosis Service Businessreportable segmentsegment assetsat 2021-09-30¥461m
Remote Image Diagnosis Service Businessreportable segmentsegment profit2020-10-01 → 2021-09-30¥73m
Total Medical Solution Businessreportable segmentcapex2020-10-01 → 2021-09-30¥32m
Total Medical Solution Businessreportable segmentdepreciation2020-10-01 → 2021-09-30¥75m
Total Medical Solution Businessreportable segmentrevenue2020-10-01 → 2021-09-30¥25.2bn
Total Medical Solution Businessreportable segmentrevenue external2020-10-01 → 2021-09-30¥25.2bn
Total Medical Solution Businessreportable segmentrevenue intersegment2020-10-01 → 2021-09-30¥128,000
Total Medical Solution Businessreportable segmentsegment assetsat 2021-09-30¥12.5bn
Total Medical Solution Businessreportable segmentsegment profit2020-10-01 → 2021-09-30¥464m
Total Of Reportable Segments And Otherssegment totalcapex2020-10-01 → 2021-09-30¥52m
Total Of Reportable Segments And Otherssegment totaldepreciation2020-10-01 → 2021-09-30¥95m
Total Of Reportable Segments And Otherssegment totalrevenue2020-10-01 → 2021-09-30¥26.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-10-01 → 2021-09-30¥26.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2020-10-01 → 2021-09-30¥128,000
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2021-09-30¥13.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2020-10-01 → 2021-09-30¥573m
Total Medical Solution Businessreportable segmentemployeesat 2022-09-30134 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,402
ItemContextValueUnit
Repayments of lease obligations fin cfCurrentYearDuration-1910000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YearDuration6400000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYearDuration－JPY
Cash dividends paid fin cfPrior1YearDuration-87778000JPY
Cash dividends paid fin cfCurrentYearDuration-78421000JPY
Dividends paid to non controlling interests fin cfPrior1YearDuration-3600000JPY
Dividends paid to non controlling interests fin cfCurrentYearDuration-6000000JPY
Net cash provided by used in financing activitiesPrior1YearDuration-298007000JPY
Net cash provided by used in financing activitiesCurrentYearDuration-120931000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration957939000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration71467000JPY
Cash and cash equivalentsPrior2YearInstant4430782000JPY
Cash and cash equivalentsPrior1YearInstant5388721000JPY
Cash and cash equivalentsPrior1YearInstant5388721000JPY
Cash and cash equivalentsCurrentYearInstant5460189000JPY
Number of consolidated subsidiariesCurrentYearInstant5
Salaries and allowances sgaPrior1YearDuration956707000JPY
Salaries and allowances sgaCurrentYearDuration971017000JPY
Provision for bonuses sgaPrior1YearDuration107817000JPY
Provision for bonuses sgaCurrentYearDuration147876000JPY
Provision for directors bonuses sgaPrior1YearDuration24700000JPY
Provision for directors bonuses sgaCurrentYearDuration26500000JPY
Retirement benefit expenses sgaPrior1YearDuration30583000JPY
Retirement benefit expenses sgaCurrentYearDuration54178000JPY
Provision for directors retirement benefits sgaPrior1YearDuration25450000JPY
Provision for directors retirement benefits sgaCurrentYearDuration50000000JPY
Provision of allowance for doubtful accounts sgaPrior1YearDuration29000JPY
Provision of allowance for doubtful accounts sgaCurrentYearDuration302000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember25235788000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember647108000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E34455-000FoodServiceReportableSegmentMember464259000JPY
Revenues from external customersPrior1YearDuration_TotalOfReportableSegmentsAndOthersMember26347156000JPY
Revenues from external customersPrior1YearDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YearDuration26347156000JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember128000JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E34455-000FoodServiceReportableSegmentMember－JPY
Transactions with other segmentsPrior1YearDuration_TotalOfReportableSegmentsAndOthersMember128000JPY
Transactions with other segmentsPrior1YearDuration_ReconcilingItemsMember-128000JPY
Transactions with other segmentsPrior1YearDuration－JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember25235916000JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember647108000JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E34455-000FoodServiceReportableSegmentMember464259000JPY
Net salesPrior1YearDuration_TotalOfReportableSegmentsAndOthersMember26347284000JPY
Net salesPrior1YearDuration_ReconcilingItemsMember-128000JPY
Net salesPrior1YearDuration26347156000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember463856000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember72596000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E34455-000FoodServiceReportableSegmentMember36601000JPY
Operating incomePrior1YearDuration_TotalOfReportableSegmentsAndOthersMember573053000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2021-09-30pass rounding
balance sheet identityconsolidated 2022-09-30pass rounding
balance sheet identitynon_consolidated 2021-09-30pass rounding
balance sheet identitynon_consolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2020-09-30pass
statement vs summary · net assetsconsolidated 2021-09-30pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2020-09-30pass
statement vs summary · net assetsnon_consolidated 2021-09-30pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2020-10-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2020-10-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2021-10-01/2022-09-30pass
statement vs summary · revenueconsolidated 2020-10-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-10-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-09-30pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsnon_consolidated 2021-09-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass